60
Participants
Start Date
March 31, 2004
Primary Completion Date
May 31, 2006
panHer
Tablets, Oral, A modified Fibonocci dose escalation system initiated at 100mg and escalating up to 880mg maximum dose (rounded down to 20mg increments based on smallest tablet size); -2 40mg -33%; -1 60mg -40%; 1 100mg --; 2 200mg 100%; 3 320mg 67%; 4 480mg 50%; 5 660mg 40%; 6 880mg 33.3%, Daily, Until DLT or study MTD is reached.
Local Institution, Scottsdale
Local Institution, Tucson
Local Institution, Los Angeles
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY